Purchase Order 75N91018P00419

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $24,441.58 on April 24, 2018, to supply laboratory supplies. The order carries no small business set-aside. Performance occurs in Marlborough, Massachusetts. Ultimate completion is May 23, 2018. The contract uses firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 27, 2018, with a ceiling value of $7,422.68. The order, issued under firm fixed pricing, calls for delivery to Bethesda, Maryland, with an ultimate completion date of July 8, 2019. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on August 8, 2019, with a ceiling value of $18,641.70 for firm fixed price procurement. The place of performance is Bethesda, Maryland 20814. No set-aside category was applied. The order ultimate completion date is August 7, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $11,440 on March 8, 2018, with completion by March 27, 2019. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. Specific scope of supply is not detailed in the award record.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on April 17, 2018, for $6,222.68 with an ultimate completion date of May 26, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific goods or services procured are not described in the source documentation.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $14,350 on December 5, 2019, for a service agreement covering scientific equipment. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and has an ultimate completion date of December 2, 2020. No set-aside was used.</p>

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed-price purchase order valued at $24,940 to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of an imaging system and associated easy-to-use software for band analysis and quantification of protein and DNA gels. The products and services will support research activities across the Laboratory of Biochemistry and...

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $16,422.00 on June 27, 2018, for an OMX standalone workstation. Place of performance is Marlborough, Massachusetts. The order is firm fixed price with an ultimate completion date of July 24, 2018.</p>

The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC valued at $17,871.00 on February 1, 2018, with an ultimate completion date of January 31, 2019. The order carries fixed-price pricing with economic price adjustment and covers scientific equipment and consumables to be delivered to Bethesda, Maryland. Global Life Sciences Solutions is a wholly owned subsidiary of Danaher Corporation and competes full-and-open without small business set-asides.